More info on Proxy voting for NNVC
EUGENE SEYMOUR
It turns out that many people have not received a proxy ballot (including me)
This is because your stock is held in “street name”
This means that the brokerage house will receive the ballot
I called my broker and he gave me the control number. That is what you need to place on your proxy (which is attached below)
So either call your broker or get into your account at your brokerage house and look for something called “my account” or something similar. The information that you need should be there.
I know that this is a pain but it’s important that the investors gain some modicum of control over the Board and thus the management
The proxy cards are attached
Eugene Seymour MD MPH
310-486-5677
On Oct 22, 2018, at 7:55 PM, EUGENE SEYMOUR < DRGENO@SEYMOUR.COM> wrote:
Dear fellow investors:
You can vote your proxy over the internet. Go to www.proxyvote.com and enter your control number. This will be the number found on the proxy postcard that you will receive by mail. Feel free to contact me after October 29th if you have any questions
Here are the issues on the table:
At this year’s annual meeting you will be asked to: (i) elect two directors and re-elect another director who will each serve for a two year term; (ii) approve our Executive Equity Incentive Plan; (iii) approve the award of warrants to purchase 250,000 shares of common stock in connection with the separation agreement of our former Chief Executive Officer; (iv) approve the award of 525,000 shares of Series A Convertible Preferred Stock to our President in connection with his employment agreement; (v) ratify the selection of our independent registered public accountants; and (vi) transact such other business as may properly come before the annual meeting. The accompanying Notice of Meeting and Proxy Statement describe these matters. We urge you to read this information carefully.
(i) OK for the two new directors but NO to the re-election of Stanley Glick
(ii) This gives too much leeway to the Board to grant these awards. I’m concerned that they will be awarded without appropriate oversight: NO
(iii) This enables me to buy shares at $2/share in three equal tranches starting next January 27th and then again in 2020 and 2021. Obviously I have no comment on this
(iv) Should we award Dr. Diwan for not starting toxicology studies, for not selecting a final drug candidate, for not consummating a shingles license agreement and for not scheduling a pre-IND meeting with the FDA. Also, for being the CEO when the stock decreased in value by 70% because none of these promised milestones have been met during this calendar year. NO!
(v) and (vi) are OK
Eugene Seymour MD MPH
310-486-5677
Attachments area
 |
Thanks for the heads up.
Thank you!
Thanks, I'll check it out. |
|
